News

Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have secured final approval from the U.S. Food and Drug Administration (USFDA) for their Abbreviated New Drug Application…
Read More...

MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with Google Cloud aimed at transforming the pharmaceutical giant into a fully…
Read More...

AbbVie has announced a major $1.4 billion investment to establish a new pharmaceutical manufacturing campus in Durham, marking a significant expansion of its U.S. production…
Read More...

Clinical-stage biotech firm BioAegis Therapeutics has entered a strategic collaboration with Prenosis to accelerate the development of a precision medicine approach for inflammatory…
Read More...

The U.S. Food and Drug Administration has approved IDVYNSO, a new once-daily, single-tablet regimen developed by Merck, for the treatment of adults living with HIV-1. The therapy is…
Read More...

The U.S. Food and Drug Administration has approved an expanded indication for Tzield (teplizumab-mzwv), allowing its use in children as young as one year old to delay the onset of stage…
Read More...

Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch of a new artificial intelligence (AI) and machine learning (ML)…
Read More...

The U.S. Food and Drug Administration has granted Priority Review to a supplemental Biologics License Application (sBLA) filed by Astellas Pharma Inc. and Pfizer Inc., seeking to expand…
Read More...

Biocon Limited has secured regulatory approval in Canada for two of its denosumab biosimilars, marking a significant expansion of its global biosimilars portfolio. The company announced…
Read More...

Biogen Inc. has entered into a definitive agreement with TJ Biopharma to acquire exclusive rights to the investigational drug felzartamab in the Greater China region, completing its…
Read More...

Eli Lilly and Company and Kelonia Therapeutics, Inc. ("Kelonia"), a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for…
Read More...

UCB has announced a definitive agreement to acquire Neurona Therapeutics in a deal aimed at strengthening its epilepsy portfolio and expanding into regenerative medicine. The…
Read More...

The European Commission has granted approval to ENFLONSIA, a preventive therapy developed by Merck & Co., for protecting newborns and infants against respiratory syncytial virus…
Read More...

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at strengthening capabilities in the rapidly growing field of antibody-drug…
Read More...

Interna Therapeutics has entered into a new research collaboration with Daiichi Sankyo to explore next-generation approaches to intracellular drug delivery, marking another step forward…
Read More...

Nucleai and Sirona Dx have announced a strategic partnership aimed at delivering a fully integrated spatial proteomics solution to pharmaceutical and biotechnology companies. The…
Read More...

Terremoto Biosciences has secured $108 million in a Series C financing round, strengthening its position in the race to develop next-generation targeted therapies for cancer and rare…
Read More...

Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech Co., Ltd. to develop and commercialize its investigational hepatitis B treatment,…
Read More...

Boehringer Ingelheim and Zai Lab have announced a new clinical collaboration aimed at advancing a novel dual-targeting strategy for difficult-to-treat cancers. The partnership will…
Read More...

Sana Biotechnology has announced a strategic collaboration with Mayo Clinic to accelerate the development of SC451, an investigational cell therapy aimed at transforming treatment for…
Read More...